Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Minimally Invasive Thoracic Surgery Market Expected to Be in 2029?
The market size of minimally invasive thoracic surgery has seen considerable growth in past years. It is predicted to expand from $4.04 billion in 2024 to $4.38 billion in 2025, marking a compound annual growth rate (CAGR) of 8.4%. The previous growth could be credited to factors such as the heightened occurrence of thoracic disorders and lung cancer, the escalating application of robotic-assisted thoracic procedures, an ageing population, enhanced patient awareness, and increased spending on healthcare.
The market for minimally invasive thoracic surgery is projected to experience robust growth in the coming years, soaring to $5.98 billion by 2029 with a CAGR of 8.1%. This expansion during the forecast period can be credited to factors such as the heightened demand for reduced hospital stays, increased adaptation of pioneering imaging and navigation technologies, growing popularity among surgeons, escalating governmental and private investments, and a rising focus on value-centred healthcare models. Key trends projected for this forecast period encompass advancements in the spheres of robot-assisted surgical systems, enhancements in the design of minimally invasive instruments, incorporation of artificial intelligence, application of augmented and virtual reality tools, and technological innovations related to 3D and 4K imaging systems.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27348&type=smp
What Are The Contributors To Demand In The Minimally Invasive Thoracic Surgery Market?
The increasing prevalence of lung diseases is anticipated to be a significant driver for the expansion of the minimally invasive thoracic surgery market in the future. Health conditions that hamper the functionality of lungs and hinder breathing, like lung cancer, pneumonia, COPD, and asthma, are grouped as lung diseases. A significant reason for the escalating number of lung diseases is tobacco smoking, as it gradually deteriorates the DNA of lung cells due to harmful chemicals, escalating the chances of unregulated cell growth and tumor development. Minimally invasive procedures provide relief to patients suffering from lung diseases by specifically targeting tumors and eliminating or annihilating them through tiny incisions or probes guided by imaging. This not only expedites the recovery process but also reduces potential harm to healthy lung tissues, minimizes the potential of complications, and fast-tracks the patient’s return to normalcy. The Centers for Disease Control and Prevention, a government agency based in the United States, reported in June 2025 that the country registered 218,893 fresh cases of lung cancer in 2022 and lung cancer was responsible for 131,584 deaths in 2023. Thus, the surge in lung diseases is fuelling the growth of the minimally invasive thoracic surgery market.
What Segmentation Categories Are Included In The Minimally Invasive Thoracic Surgery Market Analysis?
The minimally invasive thoracic surgery market covered in this report is segmented
1) By Type: Lobectomy, Wedge Resection, Pneumonectomy, Other Types
2) By Product: Energy Devices, Instruments, Staplers And Disposables, Visualization Systems
3) By Procedure Type: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Thoracic Surgery, Endoscopic Thoracic Surgery, Other Procedure Types
4) By Application: Lung Cancer Surgery, Esophageal Surgery, Mediastinal Surgery, Other Applications
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Lobectomy: Bilobectomy, Sleeve Lobectomy, Thoracoscopic Lobectomy (VATS Lobectomy), Robotic-Assisted Lobectomy
2) By Wedge Resection: Video-Assisted Thoracoscopic Surgery (VATS) Wedge Resection, Robotic-Assisted Wedge Resection, Open Wedge Resection
3) By Pneumonectomy: Standard Pneumonectomy, Extended Pneumonectomy, Sleeve Pneumonectomy, Thoracoscopic
4) By Other Types: Segmentectomy, Sleeve Resection, Decortication, Bullectomy, Thoracoscopic Resection For Metastasectomy
What Upcoming Trends Are Expected To Impact The Minimally Invasive Thoracic Surgery Market Globally?
Major players in the minimally invasive thoracic surgery market are putting their efforts into the advancement of new technology, such as robotic-assisted surgery platforms, aiming to enhance surgical precision and boost overall patient outcomes. The robotic-assisted surgery platform is a medical system that allows surgeons to use robotic arms to carry out minimally invasive operations with superior accuracy, better dexterity, and improved visualization when compared to conventional surgical procedures. For instance, in June 2024, the US-based institution Monmouth Medical Centre (MMC) launched the Ion Robotic platform, the Aliya PEF system, and intraoperative AI-driven CT imaging. The technology provides multiple advantages including improved surgical accuracy, enhanced patient results, and real-time imaging for better decision-making support. Together, these technologies facilitate minimally invasive, precise lung cancer diagnosis and treatment resulting in faster recovery and premium outcomes. Features like real-time navigation, non-thermal tumor ablation, and decreased radiation exposure further contribute to the early identification and effective treatment of the condition.
Who Are The Top-Ranked Companies In The Minimally Invasive Thoracic Surgery Market Today?
Major companies operating in the minimally invasive thoracic surgery market are Johnson And Johnson Services Inc., Medtronic Plc, Koninklijke Philips N.V., Stryker Corporation, GE Healthcare Inc., Olympus Corporation, Intuitive Surgical Operations Inc., Smith & Nephew plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Group Incorporated, CONMED Corporation, NuVasive Inc., Applied Medical Resources Corporation, KLS Martin Group, Aesculap Inc., Medela Inc., Richard Wolf GmbH, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Cmr Surgical, Genesee Biomedical Inc.
Get The Full Report Here:
How Is Minimally Invasive Thoracic Surgery Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the minimally invasive thoracic surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive thoracic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27348&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model